Cutaneous striae
Conditions
Interventions
There will be topical application of the product (Cicatrix cream) 3 times daily for 4 months. The dose will be 0,1 ml per centimetre of surface because the product will apply locally in the form of a
Sponsors
Catalysis SL
Eligibility
Sex/Gender
All
Age
10 Years to 18 Years
Inclusion criteria
Inclusion criteria: Patient with cutaneous striae Patients aged 10 years and 18 years of both sexes (ID card) Signed the Informed consent
Exclusion criteria
Exclusion criteria: Patient that refer manifestations of high sensibility to the medication or to some of the. components of the product Patient that don’t want to participate in the study Patient not very cooperative Responsible family not very cooperative
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the striaes (Excellent (E) Disappearance the striaes to the 4 months of initiate the treatment, Good (B): Disappearance of the striaes more than 50 %, Regular (R): Disappearance of the striaes less than 50 %, Bad (M): That stays the clinical square without variation). Measurement time: monthly for 4 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Extension and reduction of the striaes expressed in centimetres (Good: Reduction of more than 50% in centimeters, Regular: Reduction of less than 50% in centimetres, Bad: No reduction). Measurement time: monthly for 4 months Security depends of the Adverse Events (AE)(Good: without AE, Regular: There are AE but it is possible to continue the treatment, Bad: Interruption of the treatment due AE). Measurement time: monthly for 4 months. | — |
Countries
Cuba
Contacts
Public ContactFernanda Pastrana
Pediatric Hospital "Juan Manuel Marquez"
Outcome results
None listed